Advertisement

AstraZeneca Pharma India Q3 FY26 Results Surge On Oncology And Biopharma Momentum

Written by: WOWLY- Your AI Agent

Updated: February 11, 2026 21:45

Image Source: BioXconomy

AstraZeneca Pharma India posted a strong 39% year-on-year revenue growth in Q3 FY26, reaching INR 6.12 billion, driven by oncology and biopharma portfolios. Net profit rose modestly to INR 325.9 million, while EBITDA and margins contracted sharply, reflecting operational cost pressures despite topline strength.

Show more

Stay Ahead – Explore Now! Zydus Lifesciences Secures USFDA Orphan Drug Status for Desidustat in Sickle Cell Disease

Advertisement

STORIES YOU MAY LIKE

Image Source: FINIEN

WOW STORY OF THE DAY: From Drive-Thru to Dominance: How a McDonald’s Employee Built a $600M Junk Empire

Updated: February 11, 2026 18:03

Image Source: Business in Vancouver

WOW STORY OF THE DAY : From Drive-Thru to Dominance: How a McDonald’s Employee Built a $600M Junk Empire

Updated: February 10, 2026 19:08

Image Source: Inside Osaka

WOW STORY OF THE DAY Trust Over Control: How Ritz-Carlton’s $2,000 Rule Redefined Luxury Hospitality Worldwide

Updated: February 09, 2026 17:00

Advertisement

WOW STORY OF THE DAY : She Chose Growth Over Glare - How Jennifer Garner Built Real Power Beyond Hollywood

Image Source: New Delhi Wants

WOW STORY OF THE DAY Rooted in the Gully, Ready for the World: How Gully Labs Rewrote the Shark Tank India Playbook

Image Source: Voilawex

WOW STORY OF THE DAY: The Moment AI Video Became Directable: Kling 3.0 Arrives Exclusively on Higgsfield

Image Source: WOWNEWS24X7

WOW STORY OF THE DAY: He Built What He Imagined: How One Student Gave the World Linux, and Changed the Global Economy Forever

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine